Showing 2,392 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Resistance

Janssen to Stop Offering "Virtual Phenotype" Testing, and Musings on Progress

Editor's pick
The BodyPRO
27 November 2013
Pregnancy and vertical transmission

Pros and Cons of Uganda’s New ARV Therapy for Pregnant Women

Editor's pick
Inter Press Service
27 November 2013
Bad science & bogus treatments

Claim of ‘Self-Inflicted’ H.I.V. in Greece an Error, W.H.O. Says

Editor's pick
New York Times
26 November 2013
Bad science & bogus treatments

Rush Limbaugh Promotes A New Myth: Greeks Gave Themselves HIV For Welfare Money

Editor's pick
Media Matters
26 November 2013
Drug interactions & pharmacokinetics

Risk of Harmful Drug Interactions Rises With Age in HIV+ US Group

Editor's pick
International AIDS Society
26 November 2013
New & experimental HIV treatments

Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV

Editor's pick
European Medicines Agency
26 November 2013
Pharmaceutical industry

Hardly accessible Atripla in Eastern Europe & Central Asia

Editor's pick
EATG / EECA CAB
22 November 2013
New & experimental HIV treatments

Gilead's Vitekta Gets Approval in European Union

Editor's pick
Wall Street Journal
19 November 2013
Treatment guidelines

BHIVA Autumn Conference: Presentations now available online

Editor's pick
British HIV Association
19 November 2013
Bad science & bogus treatments

South Africa: HIV/Aids holy water cure put to the test

Editor's pick
eNCA
6 November 2013
Government, leadership & policy

Jimmy Carter almost punched Thabo Mbeki

Editor's pick
News 24
4 November 2013
Treatment guidelines

Recommendation on Integrase Inhibitor Use in Antiretroviral Treatment-Naive HIV-Infected Individuals from the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents

Editor's pick
AIDS Info
31 October 2013
Finance & funding

'Early medication for HIV is cost-effective'

Editor's pick
FRANCE 24
31 October 2013
Side effects

Differing Effects of Low- and High-Fat Meals on New Raltegravir Formulation

Editor's pick
NATAP
30 October 2013
Government, leadership & policy

WHO and UNAIDS advocate for an initiative to increase access to HIV treatment in the Eastern Mediterranean/Middle East and North Africa regions

Editor's pick
World Health Organization press release
30 October 2013
New & experimental HIV treatments

Sangamo BioSciences Presents Clinical Data From HIV Study Demonstrating Sustained Control Of Viremia

Editor's pick
Sangamo press release
29 October 2013
New & experimental HIV treatments

ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine

Editor's pick
Viiv Healthcare
23 October 2013
Changing treatment

Once-daily raltegravir for 48 weeks as maintenance therapy in Paris

Editor's pick
NATAP
22 October 2013
Treatment guidelines

Brazil pioneers treatment for everyone

Editor's pick
UNAIDS
21 October 2013
Starting treatment

Obesity did not increase time to undetectable viral loads

Editor's pick
Healio Infectious Diseases News
19 October 2013
New & experimental HIV treatments

HIV Dual Therapy Matches Standard Triple Cocktail

Editor's pick
MedPage Today
19 October 2013
New & experimental HIV treatments

MODERN Study Stopped: An NRTI-Sparing, Two-Drug Initial Regimen Disappoints Again

Editor's pick
NEJM Journal Watch
17 October 2013
The search for a cure

Elusive secret of HIV long-term immunity

Editor's pick
EurekAlert!
17 October 2013
Drug interactions & pharmacokinetics

Merck plans phase III study of once-daily raltegravir (Isentress)

Editor's pick
Merck press release
16 October 2013